Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor.
Schmid
Christoph
C
Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital of Zurich, CH-8091 Zurich, Switzerland.
Brändle
Michael
M
Zwimpfer
Cornelia
C
Zapf
Jürgen
J
Wiesli
Peter
P
D000328:Adult; D002352:Carrier Proteins / Q000097:blood*; D003404:Creatinine / Q000097:blood*; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D020249:Hormone Replacement Therapy; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000188:drug therapy; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008297:Male; D013974:Thyroxine / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
D002352:Carrier Proteins; D006023:Glycoproteins; D036341:Intercellular Signaling Peptides and Proteins; D042461:Vascular Endothelial Growth Factor A; C075944:insulin-like growth factor binding protein, acid labile subunit; C065700:myotrophin; D003404:Creatinine; D013974:Thyroxine